REVELATION BIOSCIENCES, INC. Payments to Acquire Investments to be Held in Decommissioning Trust Fund
REVELATION BIOSCIENCES, INC. (REVB) reported Payments to Acquire Investments to be Held in Decommissioning Trust Fund of $482.87 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-04-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaymentsToInvestInDecommissioningFund · last filed 2022-04-15
- REVELATION BIOSCIENCES, INC. payments to acquire investments to be held in decommissioning trust fund for fiscal 2021 was $482.87K, a 99.34% decline from fiscal 2020.
- REVELATION BIOSCIENCES, INC. payments to acquire investments to be held in decommissioning trust fund for fiscal 2020 was $73.51M.
| Period end | Payments to Acquire Investments to be Held in Decommissioning Trust Fund 12 month |
|---|---|
| 2021-12-31 | $482.87K 10-K · filed 2022-04-15 |
| 2020-12-31 | $73.51M 10-K · filed 2022-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |